Barinthus Biotherapeutics plc. — Director's Dealing 2023

Feb 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaccitech plc (VACC)
CIK: 0001828185
Period of Report: 2023-01-03

Reporting Person: Griffiths Graham (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-03	Share Option (Right to Buy)	$2.40	A	105000	Acquired	2033-01-03	Ordinary Shares (105000)	Direct

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.